Share-based payments - IPO Grant Shares (Details) - Equity Settled Awards € / shares in Units, € in Thousands |
1 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
May 31, 2023
shares
$ / shares
|
May 31, 2023
shares
€ / shares
|
Jun. 30, 2023
EUR (€)
|
Jun. 30, 2022
EUR (€)
|
|
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||
Share-based payment expenses | € | € 19 | € 0 | ||
Weighted average grant date fair value (in Eur per share) | (per share) | $ 2.13 | € 1.97 | ||
Employees Instrumental In IPO | ||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||
Granted during the period (in shares) | 100 | 100 | ||
Employees | ||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||
Granted during the period (in shares) | 9,700 | 9,700 |
X | ||||||||||
- Definition Weighted Average Fair Value Price At Measurement Date, Other Equity Instruments Granted No definition available.
|
X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
X | ||||||||||
- Definition The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|